ATA92982A - Verfahren zur herstellung einer pharmazeutischen, parenteralen dosiseinheit von na-piperacillin - Google Patents

Verfahren zur herstellung einer pharmazeutischen, parenteralen dosiseinheit von na-piperacillin

Info

Publication number: ATA92982A
Authority: AT; Austria
Prior art keywords: piperacillin; producing; dosing unit; parenteral dosing; pharmaceutical parenteral
Prior art date: 1981-03-26

Application number

AT0092982A

Other languages

English (en)

Other versions

AT395533B (de

Inventor

Bruce Edwin Haeger

Original Assignee

American Cyanamid Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1981-03-26

Filing date

1982-03-09

Publication date

1992-06-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22935482&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATA92982(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1982-03-09 Application filed by American Cyanamid Co filed Critical American Cyanamid Co

1992-06-15 Publication of ATA92982A publication Critical patent/ATA92982A/de

1993-01-25 Application granted granted Critical

1993-01-25 Publication of AT395533B publication Critical patent/AT395533B/de

Links

238000004519 manufacturing process Methods 0.000 title 1
229960002292 piperacillin Drugs 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
- A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents

Landscapes

Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

AT0092982A 1981-03-26 1982-03-09 Verfahren zur herstellung einer pharmazeutischen, parenteralen dosiseinheit von na-piperacillin AT395533B (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US24758681A	1981-03-26	1981-03-26

Publications (2)

Publication Number	Publication Date
ATA92982A true ATA92982A (de)	1992-06-15
AT395533B AT395533B (de)	1993-01-25

Family

ID=22935482

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT0092982A AT395533B (de)	1981-03-26	1982-03-09	Verfahren zur herstellung einer pharmazeutischen, parenteralen dosiseinheit von na-piperacillin

Country Status (23)

Country	Link
JP (1)	JPS57159708A (de)
AT (1)	AT395533B (de)
AU (1)	AU549784B2 (de)
BE (1)	BE892541A (de)
CA (1)	CA1209477A (de)
CH (1)	CH652306A5 (de)
DE (2)	DE19375106I2 (de)
DK (1)	DK157976C (de)
ES (1)	ES509234A0 (de)
FR (1)	FR2502624B1 (de)
GB (1)	GB2095551B (de)
GR (1)	GR78386B (de)
HK (1)	HK39189A (de)
HU (1)	HU186489B (de)
IE (1)	IE52936B1 (de)
IL (1)	IL64924A (de)
IT (1)	IT1147916B (de)
LU (1)	LU84031A1 (de)
NL (1)	NL192664C (de)
NZ (1)	NZ199632A (de)
PL (1)	PL130564B1 (de)
SE (1)	SE453153B (de)
ZA (1)	ZA82605B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6207661B1 (en)	1999-02-22	2001-03-27	Baxter International Inc.	Premixed formulation of piperacillin sodium and tazobactam sodium injection
BRPI0415531B8 (pt)	2003-10-23	2021-05-25	Otsuka Pharma Co Ltd	formulação de aripiprazol injetável estéril de liberação controlada e método para a sua preparação
ITMI20051630A1 (it) *	2005-09-02	2007-03-03	Acs Dobfar Spa	Formulazione farmaceutica sterile iniettabile contenente almeno due principi attivi
LT2170279T (lt)	2007-07-31	2018-03-12	Otsuka Pharmaceutical Co., Ltd.	Aripiprazolo suspensijos ir liofilizuotos kompozicijos gamybos būdai
CN114200057A (zh) *	2021-12-14	2022-03-18	坛墨质检科技股份有限公司	一种可替代标准溶液的抗生素类药物固体混合标准物质的制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2608507A (en) *	1949-08-20	1952-08-26	Sharp & Dohme Inc	Dialkyl sulfamyl benzoic acids
CH546783A (de) *	1971-03-11	1974-03-15	Hoffmann La Roche	Verfahren zur herstellung von penicilloinsaeurederivate.
JPS5817728B2 (ja) *	1973-11-20	1983-04-09	山之内製薬株式会社	アンピシリンナトリウムエンノセイホウ
IL47168A (en) *	1974-05-09	1979-07-25	Toyama Chemical Co Ltd	Mono or dioxo piperazino(thio)carbonylamino derivatives ofpenicillins and cephalosporins and process for producing the same
JPS52143221A (en) *	1976-05-22	1977-11-29	Yamanouchi Pharmaceut Co Ltd	Novel preparations for rectal administration
DE2623835C2 (de) *	1976-05-28	1978-03-02	C.H. Boehringer Sohn, 6507 Ingelheim	Verfahren zur Herstellung von Natriumampicillin
JPS542337A (en) *	1977-06-08	1979-01-09	Toyama Chem Co Ltd	Bactericidal composition for medical use
FR2403078A1 (fr) *	1977-09-19	1979-04-13	Lafon Labor	Nouveau procede de preparation de formes pharmaceutiques, cosmetiques ou de diagnostic
JPS54147917A (en) *	1978-05-08	1979-11-19	Sumitomo Chem Co Ltd	Ferrze-drying method
PT70225A (en) *	1978-10-03	1979-10-01	Gist Brocades Nv	Process for the preparation of sodium amoxicillin preparations
DE2925009A1 (de) *	1979-06-21	1981-01-08	Basf Ag	Zubereitung fuer substanzen, verfahren zu deren herstellung und deren verwendung

1982
- 1982-01-26 CA CA000394904A patent/CA1209477A/en not_active Expired
- 1982-01-27 AU AU79865/82A patent/AU549784B2/en not_active Expired
- 1982-01-28 GB GB8202414A patent/GB2095551B/en not_active Expired
- 1982-01-29 ZA ZA82605A patent/ZA82605B/xx unknown
- 1982-02-01 ES ES509234A patent/ES509234A0/es active Granted
- 1982-02-02 SE SE8200591A patent/SE453153B/sv not_active IP Right Cessation
- 1982-02-02 NZ NZ199632A patent/NZ199632A/en unknown
- 1982-02-03 GR GR67200A patent/GR78386B/el unknown
- 1982-02-03 IL IL64924A patent/IL64924A/xx unknown
- 1982-02-04 DK DK048382A patent/DK157976C/da active
- 1982-02-22 JP JP57026172A patent/JPS57159708A/ja active Granted
- 1982-03-09 DE DE1993175106 patent/DE19375106I2/de active Active
- 1982-03-09 DE DE19823208505 patent/DE3208505A1/de active Granted
- 1982-03-09 AT AT0092982A patent/AT395533B/de not_active IP Right Cessation
- 1982-03-12 FR FR8204196A patent/FR2502624B1/fr not_active Expired
- 1982-03-18 PL PL1982235509A patent/PL130564B1/pl unknown
- 1982-03-18 BE BE0/207599A patent/BE892541A/fr not_active IP Right Cessation
- 1982-03-19 IT IT48034/82A patent/IT1147916B/it active
- 1982-03-24 LU LU84031A patent/LU84031A1/de unknown
- 1982-03-25 HU HU82914A patent/HU186489B/hu unknown
- 1982-03-25 IE IE703/82A patent/IE52936B1/en unknown
- 1982-03-25 CH CH1857/82A patent/CH652306A5/de not_active IP Right Cessation
- 1982-03-25 NL NL8201251A patent/NL192664C/nl not_active IP Right Cessation
1989
- 1989-05-11 HK HK391/89A patent/HK39189A/xx not_active IP Right Cessation

Also Published As

Publication number	Publication date
IT8248034A0 (it)	1982-03-19
FR2502624B1 (fr)	1985-10-25
GB2095551B (en)	1984-10-03
NL192664C (nl)	1997-12-02
DK48382A (da)	1982-09-27
DK157976C (da)	1990-08-27
DE3208505A1 (de)	1982-10-21
JPS57159708A (en)	1982-10-01
CA1209477A (en)	1986-08-12
NZ199632A (en)	1985-07-12
AU549784B2 (en)	1986-02-13
IL64924A0 (en)	1982-04-30
IL64924A (en)	1985-07-31
IE52936B1 (en)	1988-04-13
BE892541A (fr)	1982-09-20
HK39189A (en)	1989-05-19
ES8302455A1 (es)	1982-12-16
NL192664B (nl)	1997-08-01
ES509234A0 (es)	1982-12-16
GB2095551A (en)	1982-10-06
PL235509A1 (de)	1982-12-20
SE453153B (sv)	1988-01-18
CH652306A5 (de)	1985-11-15
LU84031A1 (de)	1982-07-08
NL8201251A (nl)	1982-10-18
DK157976B (da)	1990-03-12
FR2502624A1 (fr)	1982-10-01
IE820703L (en)	1982-09-26
AT395533B (de)	1993-01-25
SE8200591L (sv)	1982-09-27
AU7986582A (en)	1982-09-30
GR78386B (de)	1984-09-26
DE3208505C2 (de)	1991-11-28
DE19375106I2 (de)	2006-02-16
IT1147916B (it)	1986-11-26
ZA82605B (en)	1982-12-29
PL130564B1 (en)	1984-08-31
JPH0219804B2 (de)	1990-05-07
HU186489B (en)	1985-08-28

Legal Events

Date	Code	Title	Description
2007-02-15	ELJ	Ceased due to non-payment of the annual fee

Publication	Publication Date	Title
AT377438B (de)	1985-03-25	Verfahren zur herstellung einer pharmazeutischen zusammensetzung
AT380476B (de)	1986-05-26	Verfahren zur herstellung von chinazolinderivaten
AT384022B (de)	1987-09-25	Verfahren zur herstellung von 1,2,4-triazol-3onen
AT371708B (de)	1983-07-25	Verfahren zur herstellung von pharmazeutischen einheitsdosierungsformen
ATE52892T1 (de)	1990-06-15	Verfahren zur herstellung eines gewuerzes.
AT381091B (de)	1986-08-25	Verfahren zur herstellung von neuen ergolinderivaten
DE3676049D1 (de)	1991-01-17	Verfahren zur herstellung von thermoplastischen massen.
DE3674048D1 (de)	1990-10-18	Verfahren zur herstellung von imidaten.
AT371744B (de)	1983-07-25	Verfahren zur herstellung von foerderschnecken
ATA238582A (de)	1989-11-15	Verfahren zur herstellung von neuen prolinderivaten
ATA221181A (de)	1983-10-15	Verfahren zur herstellung von einer pharmazeutischen zusammensetzung
DE3580350D1 (de)	1990-12-06	Verfahren zur herstellung einer frukto-oligosaccharose.
AT380477B (de)	1986-05-26	Verfahren zur herstellung von neuen spirothiazolidindion-derivaten
AT380005B (de)	1986-03-25	Verfahren zur herstellung von gipsprodukten
DE19375106I2 (de)	2006-02-16	Verfahren zur Herstellung einer parenteralen Dosiseinheit von lyophilisiertem N-Piperacillin
DE3767948D1 (de)	1991-03-14	Verfahren zur herstellung von tertiaeren alkylphosphanen.
AT381318B (de)	1986-09-25	Verfahren zur herstellung von neuen nitrosoharnstoffderivaten
AT377264B (de)	1985-02-25	Verfahren zur herstellung von neuen nitrosoharnstoffderivaten
DE3672289D1 (de)	1990-08-02	Verfahren zur herstellung einer polymermodifizierten elektrode.
ATA354585A (de)	1989-08-15	Verfahren zur herstellung von krebszellen bekaempfenden lymphocyten
AT378186B (de)	1985-06-25	Verfahren zur herstellung von cimetidin
EP0078853A4 (de)	1983-09-26	Verfahren zur herstellung von betachloralanin.
DE3677405D1 (de)	1991-03-14	Verfahren zur herstellung von naphthazarinderivaten.
AT369383B (de)	1982-12-27	Verfahren zur herstellung von beta-amidoethyl -ether-derivaten
ATA535281A (de)	1985-03-15	Verfahren zur herstellung von phenoxyisobutters\|ureestern